These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34187084)

  • 21. IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies.
    Audsley KM; Wagner T; Ta C; Newnes HV; Buzzai AC; Barnes SA; Wylie B; Armitage J; Kaisho T; Bosco A; McDonnell A; Cruickshank M; Fear VS; Foley B; Waithman J
    Front Immunol; 2021; 12():735133. PubMed ID: 34552594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDAC9 deficiency promotes tumor progression by decreasing the CD8
    Ning Y; Ding J; Sun X; Xie Y; Su M; Ma C; Pan J; Chen J; Jiang H; Qi C
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32554611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutting edge: CD8+ effector T cells reject tumors by direct antigen recognition but indirect action on host cells.
    Schüler T; Blankenstein T
    J Immunol; 2003 May; 170(9):4427-31. PubMed ID: 12707316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors.
    Maccalli C; Scaramuzza S; Parmiani G
    Cancer Immunol Immunother; 2009 May; 58(5):801-8. PubMed ID: 19089424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses.
    Soderquest K; Walzer T; Zafirova B; Klavinskis LS; Polić B; Vivier E; Lord GM; Martín-Fontecha A
    J Immunol; 2011 Mar; 186(6):3304-8. PubMed ID: 21307295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
    Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional tumor specific CD8 + T cells in spleen express a high level of PD-1.
    Wang Z; Chen T; Lin W; Zheng W; Chen J; Huang F; Xie X
    Int Immunopharmacol; 2020 Mar; 80():106242. PubMed ID: 32014811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma.
    Malo CS; Renner DN; Huseby Kelcher AM; Jin F; Hansen MJ; Pavelko KD; Johnson AJ
    PLoS One; 2016; 11(8):e0162064. PubMed ID: 27560502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amino acids and RagD potentiate mTORC1 activation in CD8
    Zhang Y; Hu H; Liu W; Yan SM; Li Y; Tan L; Chen Y; Liu J; Peng Z; Yuan Y; Huang W; Yu F; He X; Li B; Zhang H
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33883257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8
    Hu J; Bernatchez C; Zhang L; Xia X; Kleinerman ES; Hung MC; Hwu P; Li S
    Cancer Immunol Res; 2017 Apr; 5(4):300-311. PubMed ID: 28223282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
    Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL
    J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphatic dysfunction attenuates tumor immunity through impaired antigen presentation.
    Kimura T; Sugaya M; Oka T; Blauvelt A; Okochi H; Sato S
    Oncotarget; 2015 Jul; 6(20):18081-93. PubMed ID: 26098776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge.
    Krishnan L; Sad S; Patel GB; Sprott GD
    Cancer Res; 2003 May; 63(10):2526-34. PubMed ID: 12750276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.
    Gehrmann U; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S
    Cancer Res; 2013 Jul; 73(13):3865-76. PubMed ID: 23658368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-36β Promotes CD8
    Zhao X; Chen X; Shen X; Tang P; Chen C; Zhu Q; Li M; Xia R; Yang X; Feng C; Zhu X; Zhu Y; Sun Z; Zhang X; Lu B; Wang X
    Front Immunol; 2019; 10():1803. PubMed ID: 31447838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 1 and type 2 CD8+ effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumor.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2000 Jan; 164(2):916-25. PubMed ID: 10623840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors.
    Xue W; Brentville VA; Symonds P; Cook KW; Yagita H; Metheringham RL; Durrant LG
    Oncotarget; 2016 Dec; 7(50):83088-83100. PubMed ID: 27825115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.
    Gangaplara A; Martens C; Dahlstrom E; Metidji A; Gokhale AS; Glass DD; Lopez-Ocasio M; Baur R; Kanakabandi K; Porcella SF; Shevach EM
    PLoS Pathog; 2018 Apr; 14(4):e1006985. PubMed ID: 29672594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photosensitizer and Light Pave the Way for Cytosolic Targeting and Generation of Cytosolic CD8 T Cells Using PLGA Vaccine Particles.
    Bruno C; Waeckerle-Men Y; Håkerud M; Kündig TM; Gander B; Johansen P
    J Immunol; 2015 Jul; 195(1):166-73. PubMed ID: 26019274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.